{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:02:55Z","timestamp":1772751775640,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6980","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1038\/nature02329","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T18:40:32Z","timestamp":1079548832000},"page":"328-332","source":"Crossref","is-referenced-by-count":291,"title":["The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis"],"prefix":"10.1038","volume":"428","author":[{"given":"Igor","family":"Garkavtsev","sequence":"first","affiliation":[]},{"given":"Sergey V.","family":"Kozin","sequence":"additional","affiliation":[]},{"given":"Olga","family":"Chernova","sequence":"additional","affiliation":[]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Frank","family":"Winkler","sequence":"additional","affiliation":[]},{"given":"Edward","family":"Brown","sequence":"additional","affiliation":[]},{"given":"Gene H.","family":"Barnett","sequence":"additional","affiliation":[]},{"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnature02329_CR1","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1101\/gad.891601","volume":"15","author":"EA Maher","year":"2001","unstructured":"Maher, E. A. et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15, 1311\u20131333 (2001)","journal-title":"Genes Dev."},{"key":"BFnature02329_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/glia.440150313","volume":"15","author":"KH Plate","year":"1995","unstructured":"Plate, K. H. & Risau, W. Angiogenesis in malignant gliomas. Glia 15, 339\u2013347 (1995)","journal-title":"Glia"},{"key":"BFnature02329_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrc905","volume":"2","author":"R Kerbel","year":"2002","unstructured":"Kerbel, R. & Folkman, J. Clinical translation of angiogenesis inhibitors. Nature Rev. Cancer 2, 727\u2013739 (2002)","journal-title":"Nature Rev. Cancer"},{"key":"BFnature02329_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249\u2013257 (2000)","journal-title":"Nature"},{"key":"BFnature02329_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng1094-171","volume":"8","author":"EG Van Meir","year":"1994","unstructured":"Van Meir, E. G. et al. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genet. 8, 171\u2013176 (1994)","journal-title":"Nature Genet."},{"key":"BFnature02329_CR6","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1126\/science.7521539","volume":"265","author":"KM Dameron","year":"1994","unstructured":"Dameron, K. M., Volpert, O. V., Tainsky, M. A. & Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of trombospondin-1. Science 265, 1582\u20131584 (1994)","journal-title":"Science"},{"key":"BFnature02329_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ng1296-415","volume":"14","author":"I Garkavtsev","year":"1996","unstructured":"Garkavtsev, I., Kazarov, A., Gudkov, A. & Riabowol, K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nature Genet. 14, 415\u2013420 (1996)","journal-title":"Nature Genet."},{"key":"BFnature02329_CR8","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1128\/MCB.17.4.2014","volume":"17","author":"I Garkavtsev","year":"1997","unstructured":"Garkavtsev, I. & Riabowol, K. Extension of the replicative lifespan of human diploid fibroblasts by inhibition of the p33ING1 candidate tumour suppressor. Mol. Cell. Biol. 17, 2014\u20132019 (1997)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature02329_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/34675","volume":"391","author":"I Garkavtsev","year":"1998","unstructured":"Garkavtsev, I. et al. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 391, 295\u2013298 (1998)","journal-title":"Nature"},{"key":"BFnature02329_CR10","first-page":"2373","volume":"63","author":"M Shiseki","year":"2003","unstructured":"Shiseki, M. et al. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res. 63, 2373\u20132378 (2003)","journal-title":"Cancer Res."},{"key":"BFnature02329_CR11","doi-asserted-by":"publisher","first-page":"8734","DOI":"10.1074\/jbc.M007664200","volume":"276","author":"D Skowyra","year":"2001","unstructured":"Skowyra, D. et al. Differential association of products of alternative transcripts of the candidate tumour suppressor ING1 with the mSin3\/HDAC1 transcriptional corepressor complex. J. Biol. Chem. 276, 8734\u20138739 (2001)","journal-title":"J. Biol. Chem."},{"key":"BFnature02329_CR12","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.1128\/MCB.21.22.7629-7640.2001","volume":"21","author":"A Nourani","year":"2001","unstructured":"Nourani, A. et al. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex. Mol. Cell. Biol. 21, 7629\u20137640 (2001)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature02329_CR13","first-page":"4890","volume":"62","author":"KM Leung","year":"2002","unstructured":"Leung, K. M. et al. The candidate tumour suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2. Cancer Res. 62, 4890\u20134893 (2002)","journal-title":"Cancer Res."},{"key":"BFnature02329_CR14","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1038\/sj.onc.1202905","volume":"18","author":"T Toyama","year":"1999","unstructured":"Toyama, T. et al. Suppression of ING1 expression in sporadic breast cancer. Oncogene 18, 5187\u20135193 (1999)","journal-title":"Oncogene"},{"key":"BFnature02329_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0304-3835(99)00288-8","volume":"147","author":"E Oki","year":"1999","unstructured":"Oki, E., Maehara, Y., Tokunaga, E., Kakeji, Y. & Sugimachi, K. Reduced expression of p33ING1 and the relationship with p53 expression in human gastric cancer. Cancer Lett. 147, 157\u2013162 (1999)","journal-title":"Cancer Lett."},{"key":"BFnature02329_CR16","first-page":"927","volume":"22","author":"B Chen","year":"2003","unstructured":"Chen, B., Campos, E. I., Crawford, R., Martinka, M. & Li, G. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma. Int. J. Oncol. 22, 927\u2013931 (2003)","journal-title":"Int. J. Oncol."},{"key":"BFnature02329_CR17","first-page":"3143","volume":"60","author":"M Gunduz","year":"2000","unstructured":"Gunduz, M. et al. Genomic structure of the human ING1 gene and tumour-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res. 60, 3143\u20133146 (2000)","journal-title":"Cancer Res."},{"key":"BFnature02329_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00125480-200201000-00004","volume":"9","author":"DJ Brat","year":"2002","unstructured":"Brat, D. J., Castellano-Sanchez, A., Kaur, B. & Van Meir, E. G. Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation. Adv. Anat. Pathol. 9, 24\u201336 (2002)","journal-title":"Adv. Anat. Pathol."},{"key":"BFnature02329_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","volume":"61","author":"P Kleihues","year":"2002","unstructured":"Kleihues, P. et al. The WHO classification of tumours of the nervous system. J. Neuropathol. Exp. Neurol. 61, 215\u2013225 (2002)","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnature02329_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrc778","volume":"2","author":"RK Jain","year":"2002","unstructured":"Jain, R. K., Munn, L. L. & Fukumura, D. Dissecting tumour pathophysiology using intravital microscopy. Nature Rev. Cancer 2, 266\u2013276 (2002)","journal-title":"Nature Rev. Cancer"},{"issue":"suppl.","key":"BFnature02329_CR21","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","volume":"109","author":"S Ghosh","year":"2002","unstructured":"Ghosh, S. & Karin, M. Missing pieces in the NF-\u03baB puzzle. Cell 109 (suppl.), S81\u2013S96 (2002)","journal-title":"Cell"},{"key":"BFnature02329_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-\u03baB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301\u2013310 (2002)","journal-title":"Nature Rev. Cancer"},{"key":"BFnature02329_CR23","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/sj.onc.1202424","volume":"18","author":"I Desbaillets","year":"1999","unstructured":"Desbaillets, I., Diserens, A. C., de Tribolet, N., Hamou, M. F. & Van Meir, E. G. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 18, 1447\u20131456 (1999)","journal-title":"Oncogene"},{"key":"BFnature02329_CR24","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.186.8.1201","volume":"186","author":"I Desbaillets","year":"1997","unstructured":"Desbaillets, I., Diserens, A. C., Tribolet, N., Hamou, M. F. & Van Meir, E. G. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J. Exp. Med. 186, 1201\u20131212 (1997)","journal-title":"J. Exp. Med."},{"key":"BFnature02329_CR25","first-page":"5822","volume":"59","author":"L Xu","year":"1999","unstructured":"Xu, L., Xie, K., Mukaida, N., Matsushima, K. & Fidler, I. J. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res. 59, 5822\u20135829 (1999)","journal-title":"Cancer Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature02329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature02329","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature02329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:21:18Z","timestamp":1684434078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature02329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":25,"journal-issue":{"issue":"6980","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["BFnature02329"],"URL":"https:\/\/doi.org\/10.1038\/nature02329","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}